Role of C reactive protein and procalcitonin in the diagnosis of lower respiratory tract infection in children Post date 11 June 2021 ← Three FDA advisory panel members resign over approval of Alzheimer’s drug → The UK’s response to new variants: a story of obfuscation and chaos